Cognition Therapeutics In... (CGTX)
0.36
-0.03 (-6.74%)
At close: Apr 04, 2025, 3:59 PM
0.35
-2.03%
After-hours: Apr 04, 2025, 05:54 PM EDT
13F Institute Ownership
Total Institutes of 44 in Cognition Therapeutics expanded their positions with an increase of 5 investors compared to the previous quarter. An additional 6.81M shares, as total invested capital grew by $5.76M with ownership percentage increasing from 10.52% to 27.37%.
Top Shareholders
| Institute | Ownership | Shares | Shares % Change | Market Value | Portfolio |
|---|---|---|---|---|---|
| Bios Capital Management, LP | 14.84% | 6M | +100.00% | 4.21M | 4.47% |
| Vanguard Group Inc | 3.07% | 1.24M | -0.24% | 868.94K | < 0.01% |
| Sigma Planning Corp | 1.52% | 614.49K | +211.62% | 430.94K | 0.01% |
Stop Guessing, Start Knowing.
Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.
- Unlimited access to all data and tools
- Unlimited access to all data and tools, giving you the edge over everyone else in the market.
- Realtime Options & Dark Pool Data
- Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
- Top Wallstreet Analyst Ratings
- Follow ratings from the best analysts on Wall Street to stay ahead.
- Up to 30 years financial history
- We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.